Refaja
About Refaja
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University Medical Center Groningen
2
AstraZeneca
1
Comprehensive Cancer Centre The Netherlands
1
Radboud University Medical Center
1
Clinical Trials at Refaja
During the past decade, Refaja conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
2003-06-01
2008-07-01
Completed
551
Performance of Tension Free Vaginal Mesh (Prolift) Versus Conventional Vaginal Prolapse Surgery in Recurrent Prolapse.
2006-08-01
2015-12-01
Completed
194
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
2014-09-01
2017-04-01
Completed
355
ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More?
2015-09-01
2023-03-01
Unknown status
299
Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands
2020-07-01
2025-07-01
Recruiting
982
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Refaja"
#1 collaborator was "Cisbio Bioassays" with 1 trials as a collaborator, "Disphar International B.V." with 1 trials as a collaborator, "Dutch Cancer Society" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Leiden University Medical Center" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Refaja
According to Clinical.Site data, the most researched conditions in "Refaja" are
"Abdominal Pain" (1 trials), "Crohn's Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Diarrhea" (1 trials) and "Endometrial Cancer" (1 trials). Many other conditions were trialed in "Refaja" in a lesser frequency.
Clinical Trials Intervention Types at Refaja
Most popular intervention types in "Refaja" are "Drug" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Digoxin" (1 trials), "Exenatide (AC2993)" (1 trials), "Insulin glargine" (1 trials), "Placebos" (1 trials) and "Reduced follow-up schedule" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Refaja
The vast majority of trials in "Refaja" are
3 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Refaja
Currently, there are NaN active trials in "Refaja".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Refaja,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Refaja, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".